Özet:

INTRODUCTION: To assess the predictive role of hematological parameters on the results of prostate biopsies. METHODS: We evaluated patients who underwent ultrasound-guided prostate biopsies between January 2014 and April 2016. The patients were divided into two groups according to their histopathological results: patients with prostate detected cancer and patients without detected cancer. The erythrocyte count, neutrophil count, lymphocyte count, platelet count, hemoglobin level, hematocrit, red cell distribution width, mean platelet volume, platelet distribution width and plateletcrit were analyzed before biopsy. Additionally, neutrophil-to-lymphocyte ratios and platelet-to-lymphocyte ratios were calculated. These parameters were compared between the two groups and statistically analyzed. RESULTS: Prostate cancer was detected in 38 (30.25%) patients, and benign conditions (prostatic hyperplasia or chronic prostatitis) were detected in 88 (69.85%) patients. There was no statistically significant difference between the patients with prostate cancer and patients with benign conditions according to the erythrocyte count, neutrophil count, lymphocyte count, platelet count, hemoglobin level, hematocrit, red cell distribution width, mean platelet volume and platelet distribution width and plateletcrit. Additionally, there were no statistically significant differences between the groups regarding the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio. DISCUSSION AND CONCLUSION: Hematological parameters play no significant role in predicting prostate biopsy results. More sophisticated studies are needed to further evaluate this issue.

Anahtar Kelimeler: